Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.60
-0.12 (-1.38%)
Last updated: Jul 28, 2026, 10:02 AM CET
Svas Biosana Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 140.22 | 120.75 | 122.34 | 102.28 | 81.52 | |
Revenue Growth | 16.13% | -1.30% | 19.61% | 25.47% | 4.91% |
Cost of Revenue | 104.59 | 90.32 | 91.95 | 75.17 | 57.99 |
Gross Profit | 35.63 | 30.43 | 30.39 | 27.12 | 23.53 |
Selling, General & Admin | 16.58 | 14.46 | 13.76 | 12.68 | 11.02 |
Depreciation & Amortization Expenses | 6.08 | 5.5 | 5.68 | 5.64 | 4.88 |
Other Operating Expenses | 3.17 | 2.68 | 2.38 | 2.54 | 1.86 |
Total Operating Expenses | 25.83 | 22.65 | 21.82 | 20.86 | 17.76 |
Operating Income | 12.24 | 9.8 | 8.57 | 6.26 | 5.77 |
Interest Income | 0.08 | 0.11 | - | 0.06 | - |
Interest Expense | -4.13 | -4.36 | - | -1.86 | - |
Other Non-Operating Income (Expense) | 0.07 | -0.04 | - | -0.13 | - |
Total Non-Operating Income (Expense) | -3.97 | -4.29 | - | -1.94 | - |
Pretax Income | 9.14 | 8.01 | 6.8 | 4.66 | 4.02 |
Provision for Income Taxes | 2.37 | 2.13 | 1.67 | 1.09 | 0.86 |
Net Income | 6.77 | 5.88 | 5.13 | 3.57 | 3.16 |
Minority Interest in Earnings | -0 | 0 | 0 | 0 | 0 |
Net Income to Common | 6.77 | 5.87 | 5.12 | 3.57 | 3.16 |
Net Income Growth | 15.24% | 14.68% | 43.52% | 12.97% | 25.70% |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 4 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 4 |
Shares Change | -1.74% | -0.71% | -0.93% | 40.33% | - |
EPS (Basic) | 1.29 | 1.10 | 0.95 | 0.66 | 0.82 |
EPS (Diluted) | 1.29 | 1.10 | 0.95 | 0.66 | 0.82 |
EPS Growth | 17.28% | 15.49% | 44.87% | -19.50% | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0 | 0 | 0.52 | 1.9 | -0.08 |
Free Cash Flow Growth | - | - | -72.62% | - | - |
Free Cash Flow Per Share | - | - | 0.10 | 0.35 | -0.02 |
Dividends Per Share | - | 0.250 | 0.300 | - | - |
Dividend Growth | - | -16.67% | - | - | - |
Gross Margin | 25.41% | 25.20% | 24.84% | 26.51% | 28.86% |
Operating Margin | 8.73% | 8.12% | 7.00% | 6.12% | 7.08% |
Profit Margin | 4.83% | 4.87% | 4.19% | 3.49% | 3.88% |
FCF Margin | 0.00% | 0.00% | 0.42% | 1.86% | -0.10% |
EBITDA | 12.24 | 9.8 | 13.59 | 11.05 | 10.3 |
EBITDA Margin | 8.73% | 8.12% | 11.11% | 10.80% | 12.64% |
EBIT | 12.24 | 9.8 | 8.57 | 6.26 | 5.77 |
EBIT Margin | 8.73% | 8.12% | 7.00% | 6.12% | 7.08% |
Effective Tax Rate | 25.93% | 26.63% | 24.60% | 23.31% | 21.33% |